Literature DB >> 17295428

Understanding HSV-1 entry glycoproteins.

Adi Reske1, Gabriele Pollara, Claude Krummenacher, Benjamin M Chain, David R Katz.   

Abstract

Herpes Simplex Virus-1 is a common infectious agent, but the precise detail of entry and infection of cells has only now begun to be clarified. Four viral surface glycoproteins (gB, gD, gH and gL) are required. This review summarises the known structure and function of each of these essential viral envelope glycoproteins, and explores what is known about their close cooperation with each other in mediating cellular membrane fusion. It is suggested that, following gD binding to one of its entry receptors, membrane fusion is mediated by gB and the heterodimer gH/gL. Significantly, these four entry glycoproteins also play a key role in the interaction between HSV and the host immune system. The glycoproteins serve an important role as targets of adaptive immunity. However, recent studies have demonstrated that the same proteins also play a key role in initiating the early innate immune response to HSV. Understanding the complex functions of these HSV proteins may be essential for successful development of vaccines for HSV.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17295428      PMCID: PMC7169067          DOI: 10.1002/rmv.531

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  104 in total

1.  LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response.

Authors:  K Tamada; K Shimozaki; A I Chapoval; Y Zhai; J Su; S F Chen; S L Hsieh; S Nagata; J Ni; L Chen
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

2.  Virology: a class act.

Authors:  Theodore S Jardetzky; Robert A Lamb
Journal:  Nature       Date:  2004-01-22       Impact factor: 49.962

Review 3.  The role of macrophages and macrophage cytokines in host resistance to herpes simplex virus.

Authors:  J A Hendrzak; P S Morahan
Journal:  Immunol Ser       Date:  1994

4.  Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model.

Authors:  Roberto Manservigi; Anna Boero; Rafaela Argnani; Elisabetta Caselli; Silvia Zucchini; Vivì Miriagou; Penelope Mavromara; Michele Cilli; Maria Pia Grossi; Pier Giorgio Balboni; Enzo Cassai
Journal:  Vaccine       Date:  2005-01-04       Impact factor: 3.641

Review 5.  The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells.

Authors:  G Campadelli-Fiume; F Cocchi; L Menotti; M Lopez
Journal:  Rev Med Virol       Date:  2000 Sep-Oct       Impact factor: 6.989

6.  Isolation of a herpes simplex virus-specific antigenic fraction which stimulates the production of neutralizing antibody.

Authors:  G H Cohen; M Ponce de Leon; C Nichols
Journal:  J Virol       Date:  1972-11       Impact factor: 5.103

7.  Mutations in herpes simplex virus glycoprotein D that prevent cell entry via nectins and alter cell tropism.

Authors:  Sharmila Manoj; Cheryl R Jogger; Dawn Myscofski; Miri Yoon; Patricia G Spear
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-23       Impact factor: 11.205

8.  Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted.

Authors:  A Forrester; H Farrell; G Wilkinson; J Kaye; N Davis-Poynter; T Minson
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

9.  Identification of functional regions of herpes simplex virus glycoprotein gD by using linker-insertion mutagenesis.

Authors:  H Y Chiang; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

10.  The major neutralizing antigenic site on herpes simplex virus glycoprotein D overlaps a receptor-binding domain.

Authors:  J C Whitbeck; M I Muggeridge; A H Rux; W Hou; C Krummenacher; H Lou; A van Geelen; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

View more
  48 in total

1.  Characterisation of the epitope for a herpes simplex virus glycoprotein B-specific monoclonal antibody with high protective capacity.

Authors:  Martin P Däumer; Beate Schneider; Doris M Giesen; Sheriff Aziz; Rolf Kaiser; Bernd Kupfer; Karl E Schneweis; Jens Schneider-Mergener; Ulrich Reineke; Bertfried Matz; Anna M Eis-Hübinger
Journal:  Med Microbiol Immunol       Date:  2010-10-08       Impact factor: 3.402

2.  Primary B-cell infection with a deltaBALF4 Epstein-Barr virus comes to a halt in the endosomal compartment yet still elicits a potent CD4-positive cytotoxic T-cell response.

Authors:  Bernhard Neuhierl; Regina Feederle; Dinesh Adhikary; Birgit Hub; Karsten Geletneky; Josef Mautner; Henri-Jacques Delecluse
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

3.  Herpes simplex virus glycoprotein B associates with target membranes via its fusion loops.

Authors:  Brian P Hannah; Tina M Cairns; Florent C Bender; J Charles Whitbeck; Huan Lou; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

4.  Mechanisms of receptor/coreceptor-mediated entry of enveloped viruses.

Authors:  Sarah A Nowak; Tom Chou
Journal:  Biophys J       Date:  2009-04-08       Impact factor: 4.033

Review 5.  The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation.

Authors:  Marcos W Steinberg; Timothy C Cheung; Carl F Ware
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

6.  Different modes of herpes simplex virus type 1 spread in brain and skin tissues.

Authors:  Yael Tsalenchuck; Tomer Tzur; Israel Steiner; Amos Panet
Journal:  J Neurovirol       Date:  2014-01-10       Impact factor: 2.643

7.  Prohibitin Interacts with envelope proteins of white spot syndrome virus and prevents infection in the red swamp crayfish, Procambarus clarkii.

Authors:  Jiang-Feng Lan; Xin-Cang Li; Jie-Jie Sun; Jing Gong; Xian-Wei Wang; Xiu-Zhen Shi; Li-Jie Shi; Yu-Ding Weng; Xiao-Fan Zhao; Jin-Xing Wang
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

8.  Characterization of white spot syndrome virus envelope protein VP51A and its interaction with viral tegument protein VP26.

Authors:  Yun-Shiang Chang; Wang-Jing Liu; Tsung-Lu Chou; Yuan-Ting Lee; Tai-Lin Lee; Wei-Tung Huang; Guang-Hsiung Kou; Chu-Fang Lo
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

9.  A 3D model of the membrane protein complex formed by the white spot syndrome virus structural proteins.

Authors:  Yun-Shiang Chang; Wang-Jing Liu; Cheng-Chung Lee; Tsung-Lu Chou; Yuan-Ting Lee; Tz-Shian Wu; Jiun-Yan Huang; Wei-Tung Huang; Tai-Lin Lee; Guang-Hsiung Kou; Andrew H-J Wang; Chu-Fang Lo
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

10.  Vaccination with synthetic constructs expressing cytomegalovirus immunogens is highly T cell immunogenic in mice.

Authors:  Devon J Shedlock; Kendra T Talbott; Stephan J Wu; Christine M Wilson; Karuppiah Muthumani; Jean D Boyer; Niranjan Y Sardesai; Sita Awasthi; David B Weiner
Journal:  Hum Vaccin Immunother       Date:  2012-11-01       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.